Conservative Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma Patients
The use of intravenous bisphosphonates (pamidronate or zoledronic acid) is the cornerstone for the management of multiple myeloma-(MM-) related bone disease. However, osteonecrosis of the jaw (ONJ) is a rare, but sometimes difficult to manage, adverse effect of bisphosphonates therapy. A retrospecti...
Saved in:
Main Authors: | Pelagia I. Melea (Author), Ioannis Melakopoulos (Author), Efstathios Kastritis (Author), Christina Tesseromatis (Author), Vasileios Margaritis (Author), Meletios A. Dimopoulos (Author), Evangelos Terpos (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2014-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bisphosphonates and osteonecrosis of jaws
by: Geetha Vijay, et al.
Published: (2012) -
Conservative Surgical Management of Stage I Bisphosphonate-Related Osteonecrosis of the Jaw
by: Paolo Vescovi, et al.
Published: (2014) -
Osteonecrosis of the Jaws in Treatment with Bisphosphonates
by: M. Machálka, et al.
Published: (2006) -
Bisphosphonate-associated osteonecrosis of the jaws
by: Rajiv S Desai, et al.
Published: (2012) -
Bisphosphonate-associated osteonecrosis of the jaws
by: Pankaj Agarwal, et al.
Published: (2012)